3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
2
Pancreatic Fistula
1
Duodenal Neoplasms
1
Cholangiocarcinoma
1
Bile Duct Neoplasms
1
Interventions
Gemcitabine
22
Cisplatin
17
durvalumab
12
lenvatinib
11
Oxaliplatin
11
pembrolizumab
6
Liver Transplantation
4
Leucovorin
4
Floxuridine
4
tislelizumab
3
Taxes
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Folfox protocol
3
Fluorouracil
3
Drug Therapy
3
Capecitabine
3
Biopsy
3
Albumin-Bound Paclitaxel
3
tremelimumab
2
pemigatinib
2
olaparib
2
ivosidenib
2
irinotecan sucrosofate
2
apatinib
2
Specimen Handling
2
Injections
2
Immunoglobulin G
2
Immune Checkpoint Inhibitors
2
Fluorodeoxyglucose F18
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Cholangiocarcinoma
×
Pancreaticojejunostomy
×
Clear all
NCT07155525
2025-09-18
NBCA-MS
Minia University
Phase 3
Recruiting
194 enrolled